peppersite
Peptidesubcutaneous

Humanin

Humanin is a small peptide written into mitochondrial DNA rather than the DNA in the cell nucleus, which is unusual. It is studied for cell survival, mitochondrial function and aging biology, almost entirely in animals and cells.

Researched for
Recovery

At a glance

Type
Peptide
Given by
subcutaneous
Evidence
Not yet audited here; the reference library calls it emerging
Reported amount
Sources differ. See the source
Typical vial
20 mg in 2 mL

How much to draw

Full calculator →
Your draw
–units
Fill in the three numbers to see the draw.
Amount per dose

The reference does not report a single injectable amount for Humanin, so the amount is yours to enter. The arithmetic is the same for any vial. How to reconstitute a vial.

What sources report

Reference, not a recommendation

These are figures published elsewhere, reproduced with their source. Peppersite does not recommend an amount for Humanin or for anything else, and nothing below has been checked against the study it came from.

Standard: 4 mg/kg · Low: 2.5 mg/kg/injection
Frequency
2x/week4-12 weeks · 6-8 weeks
Route
IP
Reported by
Peptide Dosing Protocols
What it saysThe standard dosing for Humanin is 4 mg/kg administered via intraperitoneal injection twice weekly.
Reconstitution, as reported
  • reconstituted with 2 mL bacteriostatic water (10 mg/mL)
Not yet audited

We have not published an audit on Humanin. Everything below is reference material, not our own reading of the literature, treat it as a starting point for questions, not as a grade.

How it is thought to work

Humanin acts as a stress signal sent from the mitochondria back to the rest of the cell, and it helps keep cells from dying. Researchers link this to blocking BAX, a protein that triggers programmed cell death, to receptors including FPRL1 and a three-part CNTFR, gp130 and WSX-1 receptor that switches on STAT3 survival signalling, and to chaperone-mediated autophagy, the clean-up of damaged proteins. Most published work uses HNG, a lab-made version that is more stable and more potent than natural humanin. As of June 2026 there is no published human randomized trial of humanin or HNG.

In technical termsHumanin is encoded inside mitochondrial DNA and is involved in cytoprotection and neuroprotection. It has been shown to have effects on aging and cardiac health in animal studies. [Source: Peptide Dosing Protocols]

Reported side effects

Reported by users: redness, mild swelling or short-lived discomfort where it is injected, mild fatigue, occasional mild headache, and brief nausea, described more often at higher doses or when given by vein. These come from research-use community reports, not from trials.

Not ruled out: humanin blocks BAX-driven cell death, which is the clearest theoretical concern for anyone with a personal or family history of cancer. Glucose handling could shift, since insulin sensitisation shows up in animal models. Doses well above natural levels could change inflammatory tone in ways not studied in people. Animal studies have not flagged major adverse signals at the doses tested, but they were not designed to show human safety.

Who should avoid it

People with active or recent cancer: humanin blocks BAX-mediated cell death, and BAX is part of how the body clears damaged cells, so what this means for cancer surveillance is not well understood.

People who are pregnant or breastfeeding: there is no safety data in pregnancy or lactation.

Children and teenagers: there is no human safety data at any age, and even less in people still growing.

People taking insulin or drugs that make the body release insulin: humanin and HNG have insulin-sensitising effects in animal studies, so combining them with other glucose-lowering treatment could be unpredictable.

People with active autoimmune or inflammatory disease: humanin has anti-inflammatory effects, and any change to inflammatory tone is something to raise with a qualified clinician.

Anyone without qualified medical oversight, lab monitoring or sterile injection conditions: listed as a caution in the reference library, with no reason given.

Common questions

What is humanin?

Humanin is a small peptide encoded inside mitochondrial DNA, which is unusual because most peptides are encoded by the cell nucleus. It was discovered in 2001 as a factor that protected neurons from amyloid-beta toxicity.

What is HNG?

HNG is a lab-made version of humanin with the serine at position 14 swapped for glycine. That single change makes it more stable and substantially more potent, and most published animal work uses HNG rather than natural humanin.

How is humanin commonly dosed in research planning?

Reported amounts and schedules for Humanin differ by source, and peppersite does not recommend one. Each reported figure is listed in the dosing rows on this page, next to the source that reports it.

How is humanin reconstituted?

That depends on the vial size and how much water is added. The calculator on this page works out the draw for any combination, and the reconstitution guide covers the steps.

What is the half-life of humanin?

Natural humanin clears quickly, with a circulating half-life of about 30 minutes. That short half-life is part of why the more stable HNG version was developed and is used more often in research.

What route is humanin given?

Animal studies have most often used intraperitoneal injection, into the abdominal cavity. Research planning descriptions usually mention subcutaneous injection instead, under the skin.

How long is a typical humanin cycle?

Research planning descriptions mention cycles of 4 to 12 weeks. No human trial supports any particular cycle length, since none has been published.

What supplies are needed for a humanin protocol?

Descriptions of a typical research setup list the humanin or HNG vial, bacteriostatic water, U-100 insulin syringes, alcohol prep swabs and a sharps container.

Sources

The reference sections on this page come from a compound library we import, not from our own review of the studies. Our own evidence grade appears only where an audit is linked. Research use only; nothing here is medical advice or a protocol.

Studied for the same things